Source-grounded facts extracted from Quantum Genesis AI Corp.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Quantum Genesis AI Corp. entered into Intellectual Property Assignment Agreement with Naveen Kulkarni (effective 2026-04-09).
“On April 9, 2026, Quantum Genesis AI Corp. (the “Company”) entered into a confirmatory Intellectual Property Assignment Agreement (the “Assignment Agreement”) with Naveen Kulkarni, the Company’s Chief Executive Officer (the “Assignor”).”
Quantum Genesis AI Corp.: Amended Articles of Incorporation to change company name from Quantumzyme Corp. to Quantum Genesis AI Corp (effective 2026-02-11).
“The Company filed a Certificate of Amendment to the Articles of Incorporation (the “Amended Articles”) with the Secretary of State of the State of Nevada on February 11, 2026.”
Quantum Genesis AI Corp.: Amended Articles of Incorporation to change company name from Quantumzyme Corp. to Quantum Genesis AI Corp (effective 2025-11-30).
“On November 30, 2025, the Board of Directors of Quantumzyme Corp. (the “Company”) approved an amendment to the Company’s Articles of Incorporation to change the Company’s name from Quantumzyme Corp. to Quantum Genesis AI Corp. (the “Name Change”).”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.